Poster Session I — ASN Events
8:00PM - 9:30PM
Convention Centre

#lorneiandi

Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy (#101)

8:00 PM
Yara N Abo

Activation of the NLRP3 inflammasome by Hendra Virus C-protein (#105)

8:00 PM
Kristian T Barry

Features of a novel sheep model of ALI/ARDS induced by pulmonary instillation of live Streptococcus pneumoniae (#107)

8:00 PM
Rob Bischof

Antimalarial compounds the 2-Anilino 4-Amino substituted quinazolines, are irresistible and promiscuous. (#109)

8:00 PM
Hayley Bullen

An integrated atlas of innate immune cell responses to activating stimuli reveals time-, dose- and ligand-dependent axes of inflammation. (#111)

8:00 PM
Suzanne Butcher

Establishing human small intestinal monolayers to study EPEC infection (#113)

8:00 PM
Eva Chan

Smith-specific TCR-Tregs successfully treat lupus nephritis in a humanised model of disease (#115)

8:00 PM
Rachel MY Cheong

Treating influenza A exacerbations – the case for pirfenidone over glucocorticoids (#117)

8:00 PM
Julia Chitty

Clade-specific gastrointestinal microbiota modulates epithelial endoplasmic reticulum stress response (#119)

8:00 PM
Michelle Chonwerawong

Helicobacter pylori extracellular vesicles contain urease and catalase which promote bacterial survival (#121)

8:00 PM
Nina Colon

Decoding resident immune cell communication (#123)

8:00 PM
Caleb Dawson

Cumulative vaccine take of RV3-BB rotavirus vaccine observed in Indonesian infants regardless of histo-blood group antigen status (#125)

8:00 PM
Celeste M Donato

The Helicobacter pylori virulence factor, Tipa, is carried by bacterial extracellular vesicles to the nuclear compartment of host cells. (#127)

8:00 PM
Jack Emery

Mapping of critical dengue virus-host interactions by APEX proximity labelling to reveal future antiviral drug targets.  (#129)

8:00 PM
Siena Centofanti

Do anti-LPS antibodies to patient microbiota associate with worse outcomes in Crohn's disease? (#131)

8:00 PM
Wenkang Feng

Characterising the role of NKG7 in CD4+ and CD8+ T cells during malaria (#133)

8:00 PM
Teija Frame

Distribution of phenotypic antimicrobial resistance in the gastrointestinal microbiome. (#135)

8:00 PM
Emily L Gulliver

COVID-19 in Brazil: Antibody Fc-dependent Mechanisms in Natural and Vaccine-Induced Immunity (#137)

8:00 PM
Alexander Harris

Antibody Protection of Pseudomonas aeruginosa Isolates from Bloodstream Infections (#139)

8:00 PM
Sarah M Hickson

Developing a reproducible and defined protocol to differentiate human induced pluripotent stem cells into colon epithelium as a model to study colonic innate immunity and inflammatory and infectious diseases (#141)

8:00 PM
Hani Hosseini Far

Defining the fine specificity of antibody responses to polymorphic and conserved epitopes of the lead malaria vaccine antigen: Plasmodium falciparum circumsporozoite protein (#143)

8:00 PM
Alessia Hysa

Modulation of ICAM-1 on vaginal epithelial cells by a microbiome bioactive and HIV transmission (#145)

8:00 PM
Brianna Jesaveluk

Characterisation of the DNA associated with bacterial membrane vesicles from the human gut microbiota (#147)

8:00 PM
Ella L. Johnston

Exploiting rabies virus hijacking of neuronal synapse formation (#149)

8:00 PM
Stephanie J Keating

Molecular regulation of Clec9A-mediated damage recognition and antigen presentation in dendritic cells (#151)

8:00 PM
Mireille H Lahoud

HIV-1 infected macrophages can be made susceptible to Antibody Dependent Cellular Cytotoxicity by small molecule CD4 mimetics (#153)

8:00 PM
Annemarie Laumaea

Recall, breadth and longevity of humoral immunity following Omicron BA.1 and BA.2 breakthrough infection (#155)

8:00 PM
Wen Shi Lee

Temporal kinetics of functional antibody responses following naturally acquired Plasmodium vivax malaria infections (#159)

8:00 PM
Rhea Longley

The interaction between Dynamin 3 and Kelch 13 in Plasmodium falciparum (#161)

8:00 PM
Richard R Marais

Investigating the effects of short chain fatty acids on fungal pathogen host interactions (#163)

8:00 PM
Christopher J McCrory

Characterisation of an essential dynamin-like protein in the malaria parasite Plasmodium falciparum (#165)

8:00 PM
Emma McHugh

Trafficking of the RhopH complex in malaria parasites (#167)

8:00 PM
Joyanta Modak

Targeting virus-STAT interactions to generate novel attenuated ‘live’ vaccines (#169)

8:00 PM
Gregory W Moseley

Development and evaluation of novel immunotherapeutics for EBV lymphomas in preclinical models (#171)

8:00 PM
Swathi Muralidhar

Mouse GBP1 is detrimental for the host during Burkholderia thailandensis infection (#173)

8:00 PM
Garrett Ng

A novel approach to uncover cryptic cases of immunodeficiency (#175)

8:00 PM
Tahereh Noori

Age, chorioamnionitis, and the innate immune system in preterm infants (#177)

8:00 PM
Josephine C Owen

BCL-2 and BCL-XL dynamically regulate LPS-primed macrophage survival in the absence of BCL2A1 (#179)

8:00 PM
Ashlyn P Pascoe

The role of gut macrophages in gut epithelial barrier formation (#181)

8:00 PM
Sophia Piryaei

Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core (#183)

8:00 PM
Christine Langer

The Plasmodium falciparum artemisinin resistance protein Kelch 13 is required for formation of normal cytostomes and parasite feeding (#185)

8:00 PM
Stuart A Ralph

Infectious Disease Research: It’s time to think differently (#187)

8:00 PM
Tiffany Pang

Gasdermin D deficiency limits the severity of pulmonary disease during influenza A virus infection (#189)

8:00 PM
Sarah Rosli

Lipid nanoparticle-mediated delivery of RNA therapeutics to treat Mycobacterium tuberculosis infection (#191)

8:00 PM
Jan Schaefer

Streptococcus pneumoniae potently kill mesothelial and mesothelioma cells in a strain dependent manner (#193)

8:00 PM
Hui Juin Shak

The role of BTN3A1 in regulating αβ T cell responses (#195)

8:00 PM
Kezia Christilla Singgih

Characterisation of CD1c-restricted T cells recognising mycobacterial lipids (#197)

8:00 PM
Caroline Soliman

Understanding the innate immune response to Group A Streptococcus pili (#199)

8:00 PM
Risa Takahashi

Single-cell RNAseq analysis of HIV reservoir cells from viremic and virally-suppressed individuals living with HIV (#201)

8:00 PM
Sushama Telwatte

MLKL deficiency protects against sterile inflammation and immunosenescence in aged mice (#203)

8:00 PM
Emma C. Tovey Crutchfield

Covalent probe reveals Ubc13 interactome in the malaria parasite (#205)

8:00 PM
Anna Truong

Functional IL-37 receptor cell surface expression on immune cell subsets in health and disease by flow cytometry  (#207)

8:00 PM
Holly K Ung

Structural and functional characterisation of a novel gasdermin protein (#209)

8:00 PM
Joshua von Ameln

Pilus tip protein AP1 essential for Group A Streptococcus adhesion to the tonsil epithelium (#211)

8:00 PM
Alisha M Wilson

Kinetics of the innate antiviral response of equine peripheral mononuclear cells in response to Ross River virus (#213)

8:00 PM
Ka Yuen